Filing Details
- Accession Number:
- 0001179110-20-011991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 16:09:08
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-16 16:09:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1680329 | Emma Reeve | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-14 | 1,000 | $33.02 | 2,650 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-14 | 1,000 | $68.00 | 1,650 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-12-14 | 972 | $33.02 | 2,622 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-14 | 972 | $68.00 | 1,650 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-12-15 | 1,028 | $33.02 | 2,678 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 1,000 | $33.02 | 1,000 | $33.02 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-14 | 972 | $33.02 | 972 | $33.02 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-15 | 1,028 | $33.02 | 1,028 | $33.02 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,000 | 2029-01-21 | No | 4 | M | Direct | |
12,028 | 2029-01-21 | No | 4 | M | Direct | |
11,000 | 2029-01-21 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $33.63 | 2028-12-13 | 14,000 | 14,000 | Direct | |
Common Stock | Stock Option (Right to Buy) | $33.63 | 2028-12-13 | 1,167 | 1,167 | Direct | |
Common Stock | Stock Option (Right to Buy) | $51.16 | 2030-01-28 | 10,000 | 10,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2028-12-13 | 14,000 | 14,000 | Direct |
2028-12-13 | 1,167 | 1,167 | Direct |
2030-01-28 | 10,000 | 10,000 | Direct |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 29, 2020.
- Currently exercisable.
- This option award vests in thirty-six approximately equal monthly installments, commencing on January 14, 2019 and continuing on each successive monthly anniversary of thereafter, ending on the third year anniversary of the grant date.
- This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020.